Literature DB >> 32389341

The Renin-Angiotensin System in Hypertension, a Constantly Renewing Classic: Focus on the Angiotensin AT2-Receptor.

Kasper B Assersen1, Colin Sumners2, U Muscha Steckelings3.   

Abstract

It is common knowledge that the renin-angiotensin system (RAS), in particular angiotensin II acting through the angiotensin AT1-receptor (AT1R), is pivotal for the regulation of blood pressure (BP) and extracellular volume. More recent findings have revealed that the RAS is far more complex than initially thought and that it harbours additional mediators and receptors, which are able to counteract and thereby fine-tune AT1R-mediated actions. This review will focus on the angiotensin AT2-receptor (AT2R), which is one of the "counter-regulatory" receptors within the RAS. It will review and discuss data related to the role of the AT2R in regulation of BP and focus on the following 3 questions: Do peripheral AT2R have an impact on BP regulation, and, if so, does this effect become apparent only under certain conditions? Are central nervous system AT2R involved in regulation of BP, and, if so, which brain areas are involved and what are the mechanisms? Does dysfunction of AT2R contribute to the pathogenesis of hypertension in preeclampsia?
Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32389341     DOI: 10.1016/j.cjca.2020.02.095

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  7 in total

Review 1.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

Review 2.  Brain Angiotensin Type-1 and Type-2 Receptors in Physiological and Hypertensive Conditions: Focus on Neuroinflammation.

Authors:  Khalid Elsaafien; Annette D de Kloet; Eric G Krause; Colin Sumners
Journal:  Curr Hypertens Rep       Date:  2020-07-13       Impact factor: 5.369

Review 3.  Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling.

Authors:  Naureen Fatima; Sanket N Patel; Tahir Hussain
Journal:  Hypertension       Date:  2021-04-12       Impact factor: 10.190

4.  A New Look At the Mosaic Theory of Hypertension.

Authors:  Rhian M Touyz; Ross D Feldman; David G Harrison; Ernesto L Schiffrin
Journal:  Can J Cardiol       Date:  2020-03-29       Impact factor: 6.614

Review 5.  A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality.

Authors:  Serge Camelo; Mathilde Latil; Sam Agus; Waly Dioh; Stanislas Veillet; René Lafont; Pierre J Dilda
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

Review 6.  Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases.

Authors:  May Nasser Bin-Jumah; Muhammad Shahid Nadeem; Sadaf Jamal Gilani; Bismillah Mubeen; Inam Ullah; Sami I Alzarea; Mohammed M Ghoneim; Sultan Alshehri; Fahad A Al-Abbasi; Imran Kazmi
Journal:  Antioxidants (Basel)       Date:  2022-01-26

7.  Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension.

Authors:  Giovanna Castoldi; Raffaella Carletti; Silvia Ippolito; Andrea Stella; Gianpaolo Zerbini; Sara Pelucchi; Giovanni Zatti; Cira R T di Gioia
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.